<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7180238\results\search\disease\results.xml">
  <result pre="3216109200187-20 doi: 10.1128/JCM.00187-20 : Minireview Emergence of a Novel Coronavirus," exact="Severe" post="Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options"/>
  <result pre="doi: 10.1128/JCM.00187-20 : Minireview Emergence of a Novel Coronavirus, Severe" exact="Acute" post="Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options Minireview"/>
  <result pre="10.1128/JCM.00187-20 : Minireview Emergence of a Novel Coronavirus, Severe Acute" exact="Respiratory" post="Syndrome Coronavirus 2: Biology and Therapeutic Options Minireview https://orcid.org/0000-0003-4954-0748KhanSulimanabSiddiqueRabeeaabShereenMuhammad"/>
  <result pre=": Minireview Emergence of a Novel Coronavirus, Severe Acute Respiratory" exact="Syndrome" post="Coronavirus 2: Biology and Therapeutic Options Minireview https://orcid.org/0000-0003-4954-0748KhanSulimanabSiddiqueRabeeaabShereenMuhammad AdnancAliAshaqdLiuJianboeBaiQianabBashirNadiacXueMengzhouab[a],"/>
  <result pre="2: Biology and Therapeutic Options Minireview https://orcid.org/0000-0003-4954-0748KhanSulimanabSiddiqueRabeeaabShereenMuhammad AdnancAliAshaqdLiuJianboeBaiQianabBashirNadiacXueMengzhouab[a], Department of" exact="Cerebrovascular" post="Diseases, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China[b],"/>
  <result pre="Zhengzhou University, Zhengzhou, China[b], Henan Medical Key Laboratory of Translational" exact="Cerebrovascular" post="Diseases, Zhengzhou, China[c], State Key Laboratory of Virology, College"/>
  <result pre="of Virology, Chinese Academy of Sciences, Wuhan, China[e], Department of" exact="Respiratory" post="Medicine, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China"/>
  <result pre="N, Xue M. 2020. Emergence of a novel coronavirus, severe" exact="acute" post="respiratory syndrome coronavirus 2: biology and therapeutic options. J"/>
  <result pre="Xue M. 2020. Emergence of a novel coronavirus, severe acute" exact="respiratory" post="syndrome coronavirus 2: biology and therapeutic options. J Clin"/>
  <result pre="M. 2020. Emergence of a novel coronavirus, severe acute respiratory" exact="syndrome" post="coronavirus 2: biology and therapeutic options. J Clin Microbiol"/>
  <result pre="J Clin Microbiol 58:e00187-20. https://doi.org/10.1128/JCM.00187-20. epreprint: 2020-3-3epub: 2020-4-4collection: 2020-5pmc-release: 2020-4-4585e00187-20(C)" exact="American" post="Society for Microbiology, 2020This article is made available via"/>
  <result pre="the PMC Open Access Subset for unrestricted noncommercial re-use and" exact="secondary" post="analysis in any form or by any means with"/>
  <result pre="coronavirus known as SARS-CoV-2 that caused an epidemic of coronavirus" exact="disease" post="(COVID-19) in Wuhan, China. It is the third highly"/>
  <result pre="is the third highly pathogenic and transmissible coronavirus after severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome"/>
  <result pre="the third highly pathogenic and transmissible coronavirus after severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus"/>
  <result pre="third highly pathogenic and transmissible coronavirus after severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV)"/>
  <result pre="after severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) emerged in humans. The source of"/>
  <result pre="severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) emerged in humans. The source of origin,"/>
  <result pre="coronavirus known as SARS-CoV-2 that caused an epidemic of coronavirus" exact="disease" post="(COVID-19) in Wuhan, China. It is the third highly"/>
  <result pre="is the third highly pathogenic and transmissible coronavirus after severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome"/>
  <result pre="the third highly pathogenic and transmissible coronavirus after severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus"/>
  <result pre="third highly pathogenic and transmissible coronavirus after severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV)"/>
  <result pre="after severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) emerged in humans. The source of"/>
  <result pre="severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) emerged in humans. The source of origin,"/>
  <result pre="helical symmetry (1). Coronaviruses have been widely identified as causing" exact="respiratory" post="and intestinal infections in humans after the outbreak of"/>
  <result pre="Coronaviruses have been widely identified as causing respiratory and intestinal" exact="infections" post="in humans after the outbreak of severe acute respiratory"/>
  <result pre="and intestinal infections in humans after the outbreak of severe" exact="acute" post="respiratory syndrome (SARS) in Guangdong, China in 2002 and"/>
  <result pre="intestinal infections in humans after the outbreak of severe acute" exact="respiratory" post="syndrome (SARS) in Guangdong, China in 2002 and 2003"/>
  <result pre="infections in humans after the outbreak of severe acute respiratory" exact="syndrome" post="(SARS) in Guangdong, China in 2002 and 2003 (2,"/>
  <result pre="world witnessed another outbreak in the form of Middle East" exact="respiratory" post="syndrome (MERS) caused by MERS-CoV in the Middle East"/>
  <result pre="witnessed another outbreak in the form of Middle East respiratory" exact="syndrome" post="(MERS) caused by MERS-CoV in the Middle East (4,"/>
  <result pre="its resemblance to SARS-CoV (7â€&quot;9). The SARS-CoV infects ciliated bronchial" exact="epithelial" post="cells and type-II pneumocytes through angiotensin-converting enzyme 2 (ACE2)"/>
  <result pre="(ACE2) as a receptor (2, 10). MERS infects unciliated bronchial" exact="epithelial" post="cells and type-II pneumocytes by using dipeptidyl peptidase 4"/>
  <result pre="be useful in preparing against future outbreaks and continuing pathogenic" exact="infections" post="by this class of novel coronaviruses virulent to humans."/>
  <result pre="deltacoronaviruses generally infect birds, although some of them can cause" exact="infection" post="in mammals, whereas, alpha- and betacoronaviruses are known to"/>
  <result pre="NL63 (alphacoronavirus), OC43 (betacoronavirus), and MERS-CoV (betacoronavirus) can all cause" exact="infections" post="in humans (2). However, betacoronaviruses are the most important"/>
  <result pre="despite amino acid variation at some key residues, including the" exact="absence of" post="the 8a protein and the fluctuation in the number"/>
  <result pre="8b and 3c proteins in SARS-CoV2 (29). In contrast, the" exact="primary" post="protease is highly conserved between SARS-CoV-2 and SARS-CoV, with"/>
  <result pre="animal sold at the Wuhan seafood market might represent an" exact="intermediate" post="host facilitating the emergence of the virus in humans"/>
  <result pre="the globe (2, 3). During November 2002, an epidemic of" exact="pneumonia" post="with a high rate of transmission to other people"/>
  <result pre="by subsequent outbreaks in Hong Kong. In Hong Kong, a" exact="total" post="of 138 people contracted the infection within 2 weeks"/>
  <result pre="In Hong Kong, a total of 138 people contracted the" exact="infection" post="within 2 weeks after the exposure to an infected"/>
  <result pre="during June 2012, a patient infected by MERS-CoV developed severe" exact="pneumonia" post="and died in Jeddah, Saudi Arabia (1, 33). Analysis"/>
  <result pre="globally (35, 36). During December 2019, clusters of patients with" exact="atypical pneumonia" post="were reported by local health facilities in Wuhan, China."/>
  <result pre="(35, 36). During December 2019, clusters of patients with atypical" exact="pneumonia" post="were reported by local health facilities in Wuhan, China."/>
  <result pre="rapid response team was dispatched by the Chinese Center for" exact="Disease" post="Control and Prevention (China CDC) to conduct an epidemiologic"/>
  <result pre="wet animal wholesale seafood market in Wuhan, China. Later, the" exact="infectious" post="agent responsible for this atypical pneumonia was confirmed and"/>
  <result pre="in Wuhan, China. Later, the infectious agent responsible for this" exact="atypical pneumonia" post="was confirmed and reported as coronavirus SARS-CoV-2, which caused"/>
  <result pre="Wuhan, China. Later, the infectious agent responsible for this atypical" exact="pneumonia" post="was confirmed and reported as coronavirus SARS-CoV-2, which caused"/>
  <result pre="including the USA, Japan, Iran, and South Korea (38). The" exact="infection" post="rapidly spread across the globe from Wuhan, China. Therefore,"/>
  <result pre="(R0) of 2.2, meaning each patient has been spreading the" exact="infection" post="to 2.2 other individuals (39). The estimated R0 value"/>
  <result pre="Saudi Arabia to 8.1 in South Korea (36). Considering the" exact="lower" post="R0 value, the rapid increase in suspected as well"/>
  <result pre="as well confirmed cases of COVID-19 may be inferred via" exact="viral" post="transmission through the fecal-oral route and aerosol formation. Moreover,"/>
  <result pre="asymptomatic persons are thought to be potential sources of SARS-CoV-2" exact="infection" post="(40), which may have caused the rapid spread of"/>
  <result pre="has not been fully successful. To overcome these problems, a" exact="complete" post="quarantine is necessary, allowing all of the infected individuals"/>
  <result pre="patients infected with SARS-CoV, MERS-CoV, and SARS-CoV-2 range from mild" exact="respiratory" post="illness to severe acute respiratory disease (1, 17). Both"/>
  <result pre="MERS-CoV, and SARS-CoV-2 range from mild respiratory illness to severe" exact="acute" post="respiratory disease (1, 17). Both MERS and SARS patients"/>
  <result pre="and SARS-CoV-2 range from mild respiratory illness to severe acute" exact="respiratory" post="disease (1, 17). Both MERS and SARS patients in"/>
  <result pre="SARS-CoV-2 range from mild respiratory illness to severe acute respiratory" exact="disease" post="(1, 17). Both MERS and SARS patients in later"/>
  <result pre="17). Both MERS and SARS patients in later stages develop" exact="respiratory" post="distress and renal failure (1, 17). Pneumonia appears to"/>
  <result pre="and SARS patients in later stages develop respiratory distress and" exact="renal failure" post="(1, 17). Pneumonia appears to be the most frequent"/>
  <result pre="later stages develop respiratory distress and renal failure (1, 17)." exact="Pneumonia" post="appears to be the most frequent manifestation of SARS-CoV-2"/>
  <result pre="of SARS-CoV-2 infection, characterized primarily by fever, cough, dyspnea, and" exact="bilateral" post="infiltrates on chest imaging (17). The period from infection"/>
  <result pre="characterized primarily by fever, cough, dyspnea, and bilateral infiltrates on" exact="chest" post="imaging (17). The period from infection to appearance of"/>
  <result pre="and bilateral infiltrates on chest imaging (17). The period from" exact="infection" post="to appearance of symptoms varies. Generally, it is thought"/>
  <result pre="a family cluster of infections, the onset of fever and" exact="respiratory" post="symptoms occurred approximately 3 to 6 days after presumptive"/>
  <result pre="these have been designed and validated, there is currently very" exact="limited" post="information available related to the performance of these tests."/>
  <result pre="SARS-CoV-2 (42, 43). Both guidelines recommend that manipulation of potentially" exact="infectious" post="specimens should be done in a biosafety cabinet if"/>
  <result pre="is potential for splashes or generation of droplets or aerosols." exact="Viral" post="isolation (culture) should be done only in BL-3 laboratories."/>
  <result pre="found highly effective in vitro for the control of 2019-nCoV" exact="infection" post="(44). Treatment with remdesivir alone or in combination with"/>
  <result pre="to be of greater importance. Therapeutic agents targeting nucleosides, nucleotides," exact="viral" post="nucleic acids, and enzymes/proteins involved in the replication and"/>
  <result pre="coronaviruses (1). The host receptors are also associated with the" exact="viral" post="entry into host cells, thus agents targeting these receptors"/>
  <result pre="cysteine protease and transmembrane protease serine 2 can partially block" exact="viral" post="entry into the cell (48). K22 targets membrane-bound RNA"/>
  <result pre="K22 targets membrane-bound RNA synthesis in coronaviruses and inhibits double-membrane" exact="vesicle" post="formation (49), and thus could be effective against SARS-CoV-2."/>
  <result pre="MERS, thus could be effective against SARS-CoV-2. (58) DRACO Targets" exact="viral" post="dsRNA to induce apoptosis in cells containing virus Effective"/>
  <result pre="for treatment of SARS-CoV-2 infection. (60) Remdesivir Terminates transcription of" exact="viral" post="RNA transcription at premature level Effective against a broad"/>
  <result pre="Targets RdRp (RNAâ€‘dependent RNA polymerase) enzyme to inhibit synthesis of" exact="viral" post="RNA synthesis and capping of mRNA Effective against a"/>
  <result pre="Targets RdRp (RNAâ€‘dependent RNA polymerase) enzyme to inhibit synthesis of" exact="viral" post="RNA synthesis and capping of mRNA Broad spectrum and"/>
  <result pre="for SARS-CoV-2. (1) Griffithsin Targets oligosaccharides on S to block" exact="viral" post="binding with host cell Has effects against SARS/MERS-CoV and"/>
  <result pre="thus might be used against SARS-CoV-2. (62) Hexamethylene amiloride Targets" exact="viral" post="envelope to inhibit ion channel activity Has effects against"/>
  <result pre="(1, 60) Recombinant interferons Induce the innate interferon responses against" exact="viral" post="pathogens Induce immune responses through recombinant interferons, found effective"/>
  <result pre="SARS-CoV-2. (1, 60) Nitazoxanide Induces the innate interferon responses against" exact="viral" post="pathogens Induces immune responses through recombinant interferons, has been"/>
  <result pre="SARS-CoV-2. (1) Rapamycin Inhibits kinase signaling associated pathways to block" exact="viral" post="entry Effective against SARS/MERS-CoV and might possibly be effective"/>
  <result pre="(1, 65) Imatinib Inhibits kinase signaling associated pathways to block" exact="viral" post="entry Effective against SARS/MERS-CoV and might possibly be effective"/>
  <result pre="SARS-CoV-2. (1) Dasatinib Inhibits kinase signaling associated pathways to block" exact="viral" post="entry Effective against SARS/MERS-CoV and might possibly be effective"/>
  <result pre="strategy alone, as they cannot block virus entry or disrupt" exact="viral" post="nucleic acid. In contrast, thiopurine compounds, naphthalene inhibitors, protease"/>
  <result pre="antiviral drugs, including remdesivir. Both interferon alpha and beta inhibit" exact="viral" post="replication (1). The use of interferon inducers in combination"/>
  <result pre="VACCINES Effective vaccines are important to prevent and control sporadic" exact="viral" post="attacks and emerging virus-mediated epidemics, such as the recent"/>
  <result pre="the current scenario of COVID-19 outbreak, vaccination strategies based on" exact="viral" post="vectors, recombinant protein, and viral-like particles, which have been"/>
  <result pre="different regions of S, such as HP2P-M2 peptide (effective against" exact="viral" post="infections) (1), should also be considered against COVID-19. Although"/>
  <result pre="These investigations will help the control and prevention of SARS-CoV-2-mediated" exact="pneumonia" post="disease and novel emerging diseases in the future. FUTURE"/>
  <result pre="investigations will help the control and prevention of SARS-CoV-2-mediated pneumonia" exact="disease" post="and novel emerging diseases in the future. FUTURE PERSPECTIVES"/>
  <result pre="(3). Similarly, MERS-CoV became epidemic after a series of human" exact="infections" post="in 2012 in Middle Eastern countries (33). Both viruses"/>
  <result pre="were unable to reproduce the characteristics of the severe human" exact="disease" post="and mortality was not observed (57). However, some small"/>
  <result pre="(57). However, some small animals have developed clinical symptoms of" exact="disease" post="(57), such as transgenic mice expressing human ACE2, and"/>
  <result pre="specific drugs for each newly emerged virus. Moreover, only a" exact="limited" post="number of animal models are available and most of"/>
  <result pre="have been reported with potent in vitro activities, a very" exact="limited" post="number of these may have potential in the clinical"/>
  <result pre="is opportunity to test them in the current scenario of" exact="pneumonia" post="in Wuhan, China. Broad-range combinational therapies, including lopinavir and"/>
  <result pre="XieZH, ChanKH, LiPH, TanSY, ChangQ, XieJP2003Epidemiology and cause of severe" exact="acute" post="respiratory syndrome (SARS) in Guangdong, Peopleâ€™s Republic of China,"/>
  <result pre="ChanKH, LiPH, TanSY, ChangQ, XieJP2003Epidemiology and cause of severe acute" exact="respiratory" post="syndrome (SARS) in Guangdong, Peopleâ€™s Republic of China, in"/>
  <result pre="LiPH, TanSY, ChangQ, XieJP2003Epidemiology and cause of severe acute respiratory" exact="syndrome" post="(SARS) in Guangdong, Peopleâ€™s Republic of China, in February,"/>
  <result pre="OsterhausA, FouchierR2012Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi Arabia. N Engl J Med367:1814â€&quot;1820. doi:10.1056/NEJMoa1211721.23075143 6.KhanS,"/>
  <result pre="BerglundA, WangJ, ItoY, HolmesKV, MasonRJ2013Innate immune response of human alveolar" exact="type II" post="cells infected with severe acute respiratory syndrome-coronavirus. Am J"/>
  <result pre="response of human alveolar type II cells infected with severe" exact="acute" post="respiratory syndrome-coronavirus. Am J Respir Cell Mol Biol48:742â€&quot;748. doi:10.1165/rcmb.2012-0339OC.23418343"/>
  <result pre="of human alveolar type II cells infected with severe acute" exact="respiratory" post="syndrome-coronavirus. Am J Respir Cell Mol Biol48:742â€&quot;748. doi:10.1165/rcmb.2012-0339OC.23418343 11.RajVS,"/>
  <result pre="ZhengX-S, ZhaoK, ChenQ-J, DengF, LiuL-L, YanB, ZhanF-X, WangY-Y, XiaoG-F, ShiZ-L2020A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
  <result pre="MunsterVJ, HensleyLE, ZalmoutIS, KapoorA, EpsteinJH, KareshWB, DaszakP, MohammedOB, LipkinWI2014Middle East" exact="respiratory" post="syndrome coronavirus infection in dromedary camels in Saudi Arabia."/>
  <result pre="HensleyLE, ZalmoutIS, KapoorA, EpsteinJH, KareshWB, DaszakP, MohammedOB, LipkinWI2014Middle East respiratory" exact="syndrome" post="coronavirus infection in dromedary camels in Saudi Arabia. mBio5:e00884-14-e00814."/>
  <result pre="KapoorA, EpsteinJH, KareshWB, DaszakP, MohammedOB, LipkinWI2014Middle East respiratory syndrome coronavirus" exact="infection" post="in dromedary camels in Saudi Arabia. mBio5:e00884-14-e00814. doi:10.1128/mBio.00884-14. 15.SarrisJ,"/>
  <result pre="St. Johnâ€™s Wort: current evidence for use in mood and" exact="anxiety" post="disorders. J Altern Complement Med15:827â€&quot;836. doi:10.1089/acm.2009.0066.19614563 16.ItheteNL, StoffbergS, CormanVM,"/>
  <result pre="RichardsLR, SchoemanMC, DrostenC, DrexlerJF, PreiserW2013Close relative of human Middle East" exact="respiratory" post="syndrome coronavirus in bat, South Africa. Emerg Infect Dis19:1697â€&quot;1699."/>
  <result pre="SchoemanMC, DrostenC, DrexlerJF, PreiserW2013Close relative of human Middle East respiratory" exact="syndrome" post="coronavirus in bat, South Africa. Emerg Infect Dis19:1697â€&quot;1699. doi:10.3201/eid1910.130946.24050621"/>
  <result pre="LuEJ, LiangCY, PanBY, WuSJ2004Analysis on the risk factors of severe" exact="acute" post="respiratory syndromes coronavirus infection in workers from animal markets."/>
  <result pre="LiangCY, PanBY, WuSJ2004Analysis on the risk factors of severe acute" exact="respiratory" post="syndromes coronavirus infection in workers from animal markets. (In"/>
  <result pre="on the risk factors of severe acute respiratory syndromes coronavirus" exact="infection" post="in workers from animal markets. (In Chinese.)Zhonghua Liu Xing"/>
  <result pre="ManuguerraJ-C, FontanetA, DanchinA, NiccolaiN, LiY-X, WuC-I, ZhaoG-P2005Cross-host evolution of severe" exact="acute" post="respiratory syndrome coronavirus in palm civet and human. Proc"/>
  <result pre="FontanetA, DanchinA, NiccolaiN, LiY-X, WuC-I, ZhaoG-P2005Cross-host evolution of severe acute" exact="respiratory" post="syndrome coronavirus in palm civet and human. Proc Natl"/>
  <result pre="DanchinA, NiccolaiN, LiY-X, WuC-I, ZhaoG-P2005Cross-host evolution of severe acute respiratory" exact="syndrome" post="coronavirus in palm civet and human. Proc Natl Acad"/>
  <result pre="22.LauSKP, WooPCY, LiKSM, HuangY, TsoiH-W, WongBHL, WongSSY, LeungS-Y, ChanK-H, YuenK-Y2005Severe" exact="acute" post="respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc"/>
  <result pre="WooPCY, LiKSM, HuangY, TsoiH-W, WongBHL, WongSSY, LeungS-Y, ChanK-H, YuenK-Y2005Severe acute" exact="respiratory" post="syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl"/>
  <result pre="LiKSM, HuangY, TsoiH-W, WongBHL, WongSSY, LeungS-Y, ChanK-H, YuenK-Y2005Severe acute respiratory" exact="syndrome" post="coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad"/>
  <result pre="HosaniFI, TongS, Al MuhairiSSM2018Zoonotic origin and transmission of Middle East" exact="respiratory" post="syndrome coronavirus in the UAE. Zoonoses Public Health65:322â€&quot;333. doi:10.1111/zph.12435.29239118"/>
  <result pre="TongS, Al MuhairiSSM2018Zoonotic origin and transmission of Middle East respiratory" exact="syndrome" post="coronavirus in the UAE. Zoonoses Public Health65:322â€&quot;333. doi:10.1111/zph.12435.29239118 26.ChuDKW,"/>
  <result pre="pipistrelle: implications for the origin of the novel Middle East" exact="respiratory" post="syndrome coronavirus. J Virol87:8638â€&quot;8650. doi:10.1128/JVI.01055-13.23720729 28.LauSKP, ZhangL, LukHKH, XiongL,"/>
  <result pre="implications for the origin of the novel Middle East respiratory" exact="syndrome" post="coronavirus. J Virol87:8638â€&quot;8650. doi:10.1128/JVI.01055-13.23720729 28.LauSKP, ZhangL, LukHKH, XiongL, PengX,"/>
  <result pre="novel bat lineage c betacoronavirus reveals evolution of Middle East" exact="respiratory" post="syndrome-related coronavirus spike proteins for human dipeptidyl peptidase 4"/>
  <result pre="HawkeyPM2003Description and clinical treatment of an early outbreak of severe" exact="acute" post="respiratory syndrome (SARS) in Guangzhou, PR China. J Med"/>
  <result pre="and clinical treatment of an early outbreak of severe acute" exact="respiratory" post="syndrome (SARS) in Guangzhou, PR China. J Med Microbiol52:715â€&quot;720."/>
  <result pre="clinical treatment of an early outbreak of severe acute respiratory" exact="syndrome" post="(SARS) in Guangzhou, PR China. J Med Microbiol52:715â€&quot;720. doi:10.1099/jmm.0.05320-0.12867568"/>
  <result pre="MemishZA, PerlmanS, PoonLLM, SnijderEJ, StephensGM, WooPCY, ZakiAM, ZambonM, ZiebuhrJ2013Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group."/>
  <result pre="PerlmanS, PoonLLM, SnijderEJ, StephensGM, WooPCY, ZakiAM, ZambonM, ZiebuhrJ2013Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J"/>
  <result pre="34.HijawiB, AbdallatM, SayaydehA, AlqasrawiS, HaddadinA, JaarourN, El SheikhS, AlsanouriT2013Novel coronavirus" exact="infections" post="in Jordan, April 2012: epidemiological findings from a retrospective"/>
  <result pre="MERS-CoV. Nat Commun11. doi:10.1038/s41467-019-13940-6. 36.KillerbyME, BiggsHM, MidgleyCM, GerberSI, WatsonJT2020Middle East" exact="Respiratory" post="Syndrome coronavirus transmission26:191â€&quot;198. 37.ZhuN, ZhangD, WangW, LiX, YangB, SongJ,"/>
  <result pre="Nat Commun11. doi:10.1038/s41467-019-13940-6. 36.KillerbyME, BiggsHM, MidgleyCM, GerberSI, WatsonJT2020Middle East Respiratory" exact="Syndrome" post="coronavirus transmission26:191â€&quot;198. 37.ZhuN, ZhangD, WangW, LiX, YangB, SongJ, ZhaoX,"/>
  <result pre="Investigating and Research Team. 2020A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019. N Engl J Med382:727â€&quot;733. doi:10.1056/NEJMoa2001017.31978945 38.collab:"/>
  <result pre="N Engl J Med382:727â€&quot;733. doi:10.1056/NEJMoa2001017.31978945 38.collab: World Health Organization. 2020Coronavirus" exact="disease" post="2019 (COVID-19), situation report â€&quot; 35. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200224-sitrep-35-covid-19.pdf?sfvrsn=1ac4218d_2. 39.LiQ, GuanX,"/>
  <result pre="GuggemosW, SeilmaierM, DrostenC, VollmarP, ZwirglmaierK, ZangeS, WÃ¶lfelR, HoelscherM2020Transmission of 2019-nCoV" exact="infection" post="from an asymptomatic contact in Germany. N Engl J"/>
  <result pre="LoSKF, ChanKH, PoonVKM, ChanWM, IpJD, CaiJP, ChengVCC, ChenH, HuiCKM, YuenKY2020A" exact="familial" post="cluster of pneumonia associated with the 2019 novel coronavirus"/>
  <result pre="ChanWM, IpJD, CaiJP, ChengVCC, ChenH, HuiCKM, YuenKY2020A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
  <result pre="study of a family cluster. Lancet395:514â€&quot;523. doi:10.1016/S0140-6736(20)30154-9.31986261 42.collab: Centers for" exact="Disease" post="Control and Prevention. 2020 Guidelines for samples for COVID-19,"/>
  <result pre="J Med382:929â€&quot;936. doi:10.1056/NEJMoa2001191.32004427 46.ChanJFW, LauSKP, ToKKW, ChengVCC, WooPCY, YuenK-Y2015Middle East" exact="respiratory" post="syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin"/>
  <result pre="Med382:929â€&quot;936. doi:10.1056/NEJMoa2001191.32004427 46.ChanJFW, LauSKP, ToKKW, ChengVCC, WooPCY, YuenK-Y2015Middle East respiratory" exact="syndrome" post="coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol"/>
  <result pre="Microbiol Rev28:465â€&quot;522. doi:10.1128/CMR.00102-14.25810418 47.MilletJK, WhittakerGR2014Host cell entry of Middle East" exact="respiratory" post="syndrome coronavirus after two-step, furin-mediated activation of the spike"/>
  <result pre="Rev28:465â€&quot;522. doi:10.1128/CMR.00102-14.25810418 47.MilletJK, WhittakerGR2014Host cell entry of Middle East respiratory" exact="syndrome" post="coronavirus after two-step, furin-mediated activation of the spike protein."/>
  <result pre="Acad Sci U S A111:15214â€&quot;15219. doi:10.1073/pnas.1407087111.25288733 48.ShiratoK, KawaseM, MatsuyamaS2013Middle East" exact="respiratory" post="syndrome coronavirus infection mediated by the transmembrane serine protease"/>
  <result pre="Sci U S A111:15214â€&quot;15219. doi:10.1073/pnas.1407087111.25288733 48.ShiratoK, KawaseM, MatsuyamaS2013Middle East respiratory" exact="syndrome" post="coronavirus infection mediated by the transmembrane serine protease TMPRSS2."/>
  <result pre="S A111:15214â€&quot;15219. doi:10.1073/pnas.1407087111.25288733 48.ShiratoK, KawaseM, MatsuyamaS2013Middle East respiratory syndrome coronavirus" exact="infection" post="mediated by the transmembrane serine protease TMPRSS2. J Virol87:12552â€&quot;12561."/>
  <result pre="KindlerE, JÃ³nsdÃ³ttirHR, MuthD, KintJ, ForlenzaM, MÃ¼llerMA, DrostenC, ThielV, TrybalaE2014Targeting membrane-bound" exact="viral" post="RNA synthesis reveals potent inhibition of diverse coronaviruses including"/>
  <result pre="reveals potent inhibition of diverse coronaviruses including the Middle East" exact="respiratory" post="syndrome virus. PLoS Pathog10:e1004166. doi:10.1371/journal.ppat.1004166.24874215 50.RiderTH, ZookCE, BoettcherTL, WickST,"/>
  <result pre="potent inhibition of diverse coronaviruses including the Middle East respiratory" exact="syndrome" post="virus. PLoS Pathog10:e1004166. doi:10.1371/journal.ppat.1004166.24874215 50.RiderTH, ZookCE, BoettcherTL, WickST, PancoastJS,"/>
  <result pre="Virol8:45â€&quot;53. doi:10.1016/j.coviro.2014.06.002.24997250 53.Al-TawfiqJA, HinediK, GhandourJ, KhairallaH, MuslehS, UjayliA, MemishZA2014Middle East" exact="respiratory" post="syndrome coronavirus: a case-control study of hospitalized patients. Clin"/>
  <result pre="doi:10.1016/j.coviro.2014.06.002.24997250 53.Al-TawfiqJA, HinediK, GhandourJ, KhairallaH, MuslehS, UjayliA, MemishZA2014Middle East respiratory" exact="syndrome" post="coronavirus: a case-control study of hospitalized patients. Clin Infect"/>
  <result pre="McCrayPB2009Rhesus theta-defensin prevents death in a mouse model of severe" exact="acute" post="respiratory syndrome coronavirus pulmonary disease. J Virol83:11385â€&quot;11390. doi:10.1128/JVI.01363-09.19710146 55.WileyJA,"/>
  <result pre="theta-defensin prevents death in a mouse model of severe acute" exact="respiratory" post="syndrome coronavirus pulmonary disease. J Virol83:11385â€&quot;11390. doi:10.1128/JVI.01363-09.19710146 55.WileyJA, RichertLE,"/>
  <result pre="prevents death in a mouse model of severe acute respiratory" exact="syndrome" post="coronavirus pulmonary disease. J Virol83:11385â€&quot;11390. doi:10.1128/JVI.01363-09.19710146 55.WileyJA, RichertLE, SwainSD,"/>
  <result pre="in a mouse model of severe acute respiratory syndrome coronavirus" exact="pulmonary" post="disease. J Virol83:11385â€&quot;11390. doi:10.1128/JVI.01363-09.19710146 55.WileyJA, RichertLE, SwainSD, HarmsenA, BarnardDL,"/>
  <result pre="a protein cage nanoparticle enhances protection in mice against diverse" exact="respiratory" post="viruses. PLoS One4:e7142. doi:10.1371/journal.pone.0007142.19774076 56.MubarakA, AlturaikiW, HemidaMG2019Middle East respiratory"/>
  <result pre="diverse respiratory viruses. PLoS One4:e7142. doi:10.1371/journal.pone.0007142.19774076 56.MubarakA, AlturaikiW, HemidaMG2019Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV): infection, immunological response, and vaccine development."/>
  <result pre="respiratory viruses. PLoS One4:e7142. doi:10.1371/journal.pone.0007142.19774076 56.MubarakA, AlturaikiW, HemidaMG2019Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV): infection, immunological response, and vaccine development. J"/>
  <result pre="of therapeutic agents for the treatment of the Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV). Travel Med Infect Dis30:9â€&quot;18. doi:10.1016/j.tmaid.2019.06.012.31252170 59.MielechAM,"/>
  <result pre="therapeutic agents for the treatment of the Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV). Travel Med Infect Dis30:9â€&quot;18. doi:10.1016/j.tmaid.2019.06.012.31252170 59.MielechAM, KilianskiA,"/>
  <result pre="of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and" exact="viral" post="nucleocapsid protein during human coronavirus 229E replication. Antiviral Res173:104620."/>
 </snippets>
</snippetsTree>
